Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 May 1;59(5):979-987.
doi: 10.1093/rheumatology/kez348.

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk

Affiliations
Observational Study

Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk

Klara Martinsson et al. Rheumatology (Oxford). .

Abstract

Objectives: Considering growing evidence of mucosal involvement in RA induction, this study investigated circulating free secretory component (SC) in patients with either recent-onset RA or with ACPA and musculoskeletal pain.

Methods: Two prospective cohorts were studied: TIRA-2 comprising 452 recent-onset RA patients with 3 years of clinical and radiological follow-up, and TIRx patients (n = 104) with ACPA IgG and musculoskeletal pain followed for 290 weeks (median). Blood donors and three different chronic inflammatory diseases served as controls. Free SC was analysed by sandwich ELISA.

Results: Serum levels of free SC were significantly higher in TIRA-2 patients compared with TIRx and all control groups (P < 0.01). Among TIRx patients who subsequently developed arthritis, free SC levels were higher compared with all control groups (P < 0.05) except ankylosing spondylitis (P = 0.74). In TIRA-2, patients with ACPA had higher baseline levels of free SC compared with ACPA negative patients (P < 0.001). Free SC status at baseline did not predict radiographic joint damage or disease activity over time. In TIRx, elevated free SC at baseline trendwise associated with arthritis development during follow-up (P = 0.066) but this disappeared when adjusting for confounders (P = 0.72). Cigarette smoking was associated with higher levels of free SC in both cohorts.

Conclusion: Serum free SC levels are increased in recent-onset RA compared with other inflammatory diseases, and associate with ACPA and smoking. Free SC is elevated before arthritis development among ACPA positive patients with musculoskeletal pain, but does not predict arthritis development. These findings support mucosal engagement in RA development.

Keywords: clinical progress; cyclic citrullinated peptide antibodies (ACPA); free secretory component; musculoskeletal pain; rheumatoid arthritis (RA).

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
Serum free SC in recent-onset RA (TIRA-2), ACPA-positive patients with musculoskeletal pain (TIRx) and controls Control groups comprise SLE, AAV, AS and healthy blood donors. Bars denote mean (red) and s.d. (black). Comparisons between the different groups (analysed using Mann–Whitney test) with corresponding P-values are displayed in the inset table. AAV: ANCA-associated vasculitis; SC: secretory component.
<sc>Fig</sc>. 2
Fig. 2
Serum free SC in relation to ACPA IgG and smoking (A) Serum levels of free SC according to ACPA IgG status among patients with recent-onset RA (TIRA-2). (B) Free SC levels according to smoking status in TIRA-2 and ACPA-positive patients with musculoskeletal pain (TIRx). Differences were tested by Mann–Whitney test. Bars denote mean (red) and s.d. (black). SC: secretory component.
<sc>Fig</sc>. 3
Fig. 3
Correlations between baseline levels of free SC and different ACPAs Correlation test between free SC and SC-ACPA (A), ACPA IgM (B), ACPA IgA (C) and ACPA IgG (D) in recent-onset RA (TIRA-2). Correlation statistics were obtained from Spearman tests. SC: secretory component; SC-ACPA: SC-containing ACPA.

Similar articles

Cited by

References

    1. Klareskog L, Malmstrom V, Lundberg K, Padyukov L, Alfredsson L.. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011;23:92–8. - PubMed
    1. Brink M, Hansson M, Mathsson-Alm L. et al. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis. Arthritis Res Ther 2016;18:43. - PMC - PubMed
    1. van de Sande MG, de Hair MJ, van der Leij C. et al. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011;70:772–7. - PubMed
    1. Catrina AI, Deane KD, Scher JU.. Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis. Rheumatology (Oxford) 2016;55:391–402. - PMC - PubMed
    1. Svard A, Kastbom A, Reckner-Olsson A, Skogh T.. Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res Ther 2008;10:R75. - PMC - PubMed

Publication types

MeSH terms